Patents by Inventor Samuel Aparicio

Samuel Aparicio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240409990
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques. such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: February 14, 2024
    Publication date: December 12, 2024
    Applicant: PACBRIDGE PARTNERS II INVESTMENT CO., LTD.
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Publication number: 20230348999
    Abstract: The present invention relates, in part, to methods for the stratification, prognosis, diagnosis and stratification of a cancer, such as an ovarian cancer or a breast cancer.
    Type: Application
    Filed: June 2, 2023
    Publication date: November 2, 2023
    Inventors: Sohrab SHAH, Yikan WANG, Ali Bashashati SAGHEZCHI, David HUNTSMAN, Samuel APARICIO, Andrew MCPHERSON, Diljot GREWAL
  • Publication number: 20220275463
    Abstract: The present invention relates, in part, to methods for the stratification, prognosis, diagnosis and stratification of a cancer, such as an ovarian cancer or a breast cancer.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 1, 2022
    Inventors: Sohrab SHAH, Yikan WANG, Ali Bashashati SAGHEZCHI, David HUNTSMAN, Samuel APARICIO, Andrew MCPHERSON, Diljot GREWAL
  • Publication number: 20210155980
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: January 21, 2021
    Publication date: May 27, 2021
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Patent number: 10934580
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 2, 2021
    Assignee: CANEXIA HEALTH INC.
    Inventors: Samuel Aparicio, Sohrab Shah, Rosalia Aguirre-Hernandez, Leah Prentice, Patrick Franchini, Jaswinder Singh Khattra, Tong He
  • Publication number: 20200308650
    Abstract: The present invention relates, in part, to methods for the stratification, prognosis, diagnosis and stratification of a cancer, such as an ovarian cancer or a breast cancer.
    Type: Application
    Filed: April 23, 2018
    Publication date: October 1, 2020
    Inventors: Sohrab SHAH, Yikan WANG, Ali Bashashati SAGHEZCHI, David HUNTSMAN, Samuel APARICIO, Andrew MCPHERSON, Diljot GREWAL
  • Publication number: 20180258479
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: September 23, 2016
    Publication date: September 13, 2018
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Publication number: 20100311077
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, the method comprising determining whether a candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which the Gpr100 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, or a sequence which is at least 90% identical thereto.
    Type: Application
    Filed: March 16, 2010
    Publication date: December 9, 2010
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Samuel Aparicio, John Dixon, Alan Hendrick, Jennifer M. Horwood, Dirk Zahn
  • Publication number: 20100272647
    Abstract: We disclose BACH G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO. 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof Nucleic acids capable of encoding BACH polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID No. 1, SEQ ID No.2 or SEQ ID NO: 4 or a mouse BACH genomic sequence (SEQ ID NO: 10).
    Type: Application
    Filed: November 4, 2009
    Publication date: October 28, 2010
    Applicant: Takeda Pharmaceutical Co. Ltd.
    Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
  • Publication number: 20100158807
    Abstract: We disclose a method of treating or preventing a disease selected from the group consisting of: a bladder disease, a bladder disorder, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, including overflow and urge incontinence, urinary urge, cystitis, including interstitial cystitis and overactive bladder.
    Type: Application
    Filed: October 7, 2009
    Publication date: June 24, 2010
    Applicant: TAKEDA PHARMACEUTICAL CO. LTD.
    Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
  • Publication number: 20080269118
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, the method comprising determining whether a candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which the Gpr100 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, or a sequence which is at least 90% identical thereto.
    Type: Application
    Filed: December 21, 2006
    Publication date: October 30, 2008
    Inventors: Samuel Aparicio, John Dixon, Alan Hendrick, Jennifer Marie Horwood, Dirk Zahn
  • Publication number: 20060015954
    Abstract: The present invention relates to novel functions of a known receptor. In particular, the invention relates to the use of a galanin-like receptor and/or ligands thereof in the manipulation of the pituitary hormonal axis and reproductive systems.
    Type: Application
    Filed: April 25, 2005
    Publication date: January 19, 2006
    Inventors: Samuel Aparicio, William Colledge, John Dixon, Alan Hendrick, Sophie Messager, Rosemary Thresher, Dirk Zahn
  • Publication number: 20050160486
    Abstract: We disclose a method of treating or preventing a disease selected from the group consisting of: a bladder disease, a bladder disorder, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, including overflow and urge incontinence, urinary urge, cystitis, including interstitial cystitis and overactive bladder.
    Type: Application
    Filed: July 27, 2004
    Publication date: July 21, 2005
    Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
  • Publication number: 20050064549
    Abstract: We disclose Conrad G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 14 or SEQ ID NO: 17 and homologues, variants and derivatives thereof. Nucleic acids capable of encoding Conrad polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 16 or SEQ ID NO: 18.
    Type: Application
    Filed: April 16, 2004
    Publication date: March 24, 2005
    Inventors: Samuel Aparicio, Mark Carlton, Philip Mitchell
  • Publication number: 20050026825
    Abstract: We disclose Mowgli G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 8, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding Mowgli polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 7 or SEQ ID NO: 10.
    Type: Application
    Filed: November 14, 2003
    Publication date: February 3, 2005
    Inventors: Mark Carlton, Samuel Aparicio, John Dixon, Rosemary Thresher, Dirk Zahn
  • Publication number: 20040025199
    Abstract: We disclose BACH G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding BACH polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 4 or a mouse BACH genomic sequence (SEQ ID NO:10).
    Type: Application
    Filed: May 6, 2003
    Publication date: February 5, 2004
    Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher